Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Ross Stores (ROST) Expected to Beat Earnings Estimates: Should You Buy?
Ross Stores (ROST) Expected to Beat Earnings Estimates: Should You Buy?

Ross Stores (ROST) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus outlook gives

Best Momentum Stocks to Buy for August 14th
Best Momentum Stocks to Buy for August 14th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 14th:

Microvast Holdings, Inc. MVST: This battery technology and energy storage

Cathie Wood's ARK ETFs See Record Investor Rush
Cathie Wood's ARK ETFs See Record Investor Rush

After years of outflows and underperformance, Cathie Wood’s ARK ETFs are burning hot, pulling in massive capital. The firm’s 13 U.S.-listed ETFs have gathered $3.7 billion in AUM over the past week

Wall Street Analysts Predict an 114.88% Upside in The Beachbody Company (BODI): Here's  What You Should Know
Wall Street Analysts Predict an 114.88% Upside in The Beachbody Company (BODI): Here's What You Should Know

Shares of The Beachbody Company, Inc. (BODI) have gained 27.3% over the past four weeks to close the last trading session at $5.04, but there could still be a solid upside left in the stock if

Newmark Group (NMRK)'s Technical Outlook is Bright After Key Golden Cross
Newmark Group (NMRK)'s Technical Outlook is Bright After Key Golden Cross

Newmark Group, Inc. (NMRK) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, NMRK's 50-day simple moving average crossed

Wall Street Analysts Predict a 44.79% Upside in Arcutis Biotherapeutics (ARQT): Here's  What You Should Know
Wall Street Analysts Predict a 44.79% Upside in Arcutis Biotherapeutics (ARQT): Here's What You Should Know

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.63, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High?

Amneal Pharmaceuticals (AMRX) closed the last trading session at $9.4, gaining 13.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Does Bicara Therapeutics Inc. (BCAX) Have the Potential to Rally 187.73% as Wall Street Analysts Expect?
Does Bicara Therapeutics Inc. (BCAX) Have the Potential to Rally 187.73% as Wall Street Analysts Expect?

Shares of Bicara Therapeutics Inc. (BCAX) have gained 5% over the past four weeks to close the last trading session at $11.33, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts Believe Deluxe (DLX) Could Rally 37.04%: Here's is How to Trade
Wall Street Analysts Believe Deluxe (DLX) Could Rally 37.04%: Here's is How to Trade

Deluxe (DLX) closed the last trading session at $19.52, gaining 21.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Phinia (PHIN)'s Technical Outlook is Bright After Key Golden Cross
Phinia (PHIN)'s Technical Outlook is Bright After Key Golden Cross

After reaching an important support level, PHINIA Inc. (PHIN) could be a good stock pick from a technical perspective. PHIN recently experienced a "golden cross" event, which saw its 50-day simple

Wall Street Analysts Believe El Pollo Loco (LOCO) Could Rally 28.62%: Here's is How to Trade
Wall Street Analysts Believe El Pollo Loco (LOCO) Could Rally 28.62%: Here's is How to Trade

Shares of El Pollo Loco Holdings (LOCO) have gained 1% over the past four weeks to close the last trading session at $10.69, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts Believe Natural Gas Services (NGS) Could Rally 41.66%: Here's is How to TradePhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Wall Street Analysts Believe Natural Gas Services (NGS) Could Rally 41.66%: Here's is How to Trade

Shares of Natural Gas Services (NGS) have gained 6.8% over the past four weeks to close the last trading session at $25.59, but there could still be a solid upside left in the stock if short-term

Bears are Losing Control Over Clearway Energy (CWENA), Here's Why It's a 'Buy' Now
Bears are Losing Control Over Clearway Energy (CWENA), Here's Why It's a 'Buy' Now

The price trend for Clearway Energy (CWENA) has been bearish lately and the stock has lost 9% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session

Does Syndax (SNDX) Have the Potential to Rally 158.36% as Wall Street Analysts Expect?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Does Syndax (SNDX) Have the Potential to Rally 158.36% as Wall Street Analysts Expect?

Syndax Pharmaceuticals (SNDX) closed the last trading session at $13.45, gaining 45.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Maximus (MMS) Just Flashed Golden Cross Signal: Do You Buy?
Maximus (MMS) Just Flashed Golden Cross Signal: Do You Buy?

After reaching an important support level, Maximus, Inc. (MMS) could be a good stock pick from a technical perspective. MMS recently experienced a "golden cross" event, which saw its 50-day simple

Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Shares of Amarin (AMRN) have been struggling lately and have lost 5.4% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the

XCel Brands (XELB) Reports Q2 Loss, Misses Revenue Estimates
XCel Brands (XELB) Reports Q2 Loss, Misses Revenue Estimates

XCel Brands (XELB) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.5. This compares to a loss of $0.1 per share a year ago. These figures are

Navigating Volatility: VIPS, LRN, HSBC & FUTU Stocks Could Shine Now
Navigating Volatility: VIPS, LRN, HSBC & FUTU Stocks Could Shine Now

The stock market is likely to stay volatile because, although hopes of an interest rate cut are boosting sentiment, there are still many uncertainties. Stock prices are also high compared to

Here's Why Walmart (WMT) is a Strong Momentum Stock
Here's Why Walmart (WMT) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Zebra Technologies (ZBRA) is a Strong Momentum Stock
Here's Why Zebra Technologies (ZBRA) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Merit Medical (MMSI) is a Top-Ranked Momentum Stock: Should You Buy?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Merit Medical (MMSI) is a Top-Ranked Momentum Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Here's Why Qorvo (QRVO) is a Strong Momentum Stock
Here's Why Qorvo (QRVO) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Here's Why Newmont Corporation (NEM) is a Strong Momentum Stock
Here's Why Newmont Corporation (NEM) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different